Breast Cancer Drugs Market Research Reports

Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence - Product Thumbnail Image

Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence

  • Report
  • 215 Pages
From
Breast Cancer - First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast Cancer - Product Thumbnail Image

Breast Cancer - First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast Cancer

  • Report
  • 122 Pages
From
Drug Overview: Lupron - Product Thumbnail Image

Drug Overview: Lupron

  • Drug Pipelines
  • 9 Pages
From
Drug Overview: Zoladex - Product Thumbnail Image

Drug Overview: Zoladex

  • Drug Pipelines
  • 8 Pages
From
Breast Cancer Therapeutics in Southeast Asia Markets to 2022 - Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market - Product Thumbnail Image

Breast Cancer Therapeutics in Southeast Asia Markets to 2022 - Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market

  • Report
  • 176 Pages
From
Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence - Product Thumbnail Image

Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence

  • Report
  • 170 Pages
From
Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence - Product Thumbnail Image

Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence

  • Report
  • 171 Pages
From
Breast Cancer: Triple - Negative: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis - Product Thumbnail Image

Breast Cancer: Triple - Negative: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

  • Drug Pipelines
  • 290 Pages
From
Breast Cancer: Hr+/Her2-: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis - Product Thumbnail Image

Breast Cancer: Hr+/Her2-: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

  • Drug Pipelines
  • 273 Pages
From
CAS 2-Methoxy-5-fluorouracil World Consumption Report - Product Thumbnail Image

CAS 2-Methoxy-5-fluorouracil World Consumption Report

  • Report
  • 2087 Pages
CAS 89778-27-8 Toremifene citrate Chemical World Report - Product Thumbnail Image

CAS 89778-27-8 Toremifene citrate Chemical World Report

  • Report
  • 2085 Pages
CAS 89778-26-7 Toremifene Chemical World Report - Product Thumbnail Image

CAS 89778-26-7 Toremifene Chemical World Report

  • Report
  • 2040 Pages
CAS 6055-19-2 Cyclophosphamide monohydrate Chemical World Report - Product Thumbnail Image

CAS 6055-19-2 Cyclophosphamide monohydrate Chemical World Report

  • Report
  • 2001 Pages
CAS 231277-92-2 Lapatinib Chemical World Report - Product Thumbnail Image

CAS 231277-92-2 Lapatinib Chemical World Report

  • Report
  • 2009 Pages
CAS 25316-40-9 Doxorubicin hydrochloride Chemical World Report - Product Thumbnail Image

CAS 25316-40-9 Doxorubicin hydrochloride Chemical World Report

  • Report
  • 2005 Pages
CAS 33069-62-4 Paclitaxel Chemical World Report - Product Thumbnail Image

CAS 33069-62-4 Paclitaxel Chemical World Report

  • Report
  • 2028 Pages
CAS 10540-29-1 Tamoxifen Chemical World Report - Product Thumbnail Image

CAS 10540-29-1 Tamoxifen Chemical World Report

  • Report
  • 2018 Pages
CAS 112809-51-5 Letrozole Chemical World Report - Product Thumbnail Image

CAS 112809-51-5 Letrozole Chemical World Report

  • Report
  • 2197 Pages
CAS 7413-34-5 Sodium methotrexate Chemical World Report - Product Thumbnail Image

CAS 7413-34-5 Sodium methotrexate Chemical World Report

  • Report
  • 2006 Pages
CAS 76-43-7 Fluoxymesterone Chemical World Report - Product Thumbnail Image

CAS 76-43-7 Fluoxymesterone Chemical World Report

  • Report
  • 2179 Pages
Loading Indicator

Over a million women worldwide are diagnosed with breast cancer annually. Alongside surgery, radiotherapy and immunotherapy, pharmaceutical products (including hormonal therapy and chemotherapy) are in the frontline against this terrible disease. Market reports in this section enable buyers to read up on the latest breast cancer drug pipelines and R&D strategies, as well as the medical and commercial activities of major players and niche operators such Abraxis Bioscience, Aeterna Zentaris, Agendia BV, Aphton Corp, Array BioPharma, AstraZeneca Plc, Bristol Myers Squibb, Dendreon Corporation, Eli Lilly, Genentech, Genta, Novartis AG, Pfizer, Roche Group, Sanofi-Aventis, Schering AG, Therion Biologics, and ViRexx Medical. Also included are cutting edge academic journals and various expert textbooks for medical professionals involved in breast cancer treatment. Show Less Read more

adroll